Metraipolis › archive › dc_f3ee9fe346db

Targeting SARS-CoV-2 main protease for the discovery of a broad-spectrum COVID-19 inhibitor by intensive multi-tiered validation — Europe PMC PMID:41311409

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41311409
DOI
10.1016/j.apsb.2025.09.033
License (as archived)
solo-consultazione
Archived
2026-11-09T20:03:26.174Z
SHA-256 of the archived text
baae81888132c6b603b92d4b80125bf85af91b9aa1a8e64c7daef779195652c2
Stable URL of this page
https://metraipolis.com/documento/dc_f3ee9fe346db

How to cite

Targeting SARS-CoV-2 main protease for the discovery of a broad-spectrum COVID-19 inhibitor by intensive multi-tiered validation — Europe PMC PMID:41311409 — Europe PMC (en), https://europepmc.org/article/MED/41311409 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f3ee9fe346db (Metraipolis archive dc_f3ee9fe346db, sha256 baae81888132c6b603b92d4b80125bf85af91b9aa1a8e64c7daef779195652c2)
BibTeX
@misc{dcf3ee9fe346db,
  title = {Targeting SARS-CoV-2 main protease for the discovery of a broad-spectrum COVID-19 inhibitor by intensive multi-tiered validation — Europe PMC PMID:41311409},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41311409},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f3ee9fe346db; sha256 baae81888132c6b603b92d4b80125bf85af91b9aa1a8e64c7daef779195652c2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41311409. Agents can read the archived copy with the MCP tool read_document.